Market Value735,966,000
Total Holdings76
File Date2022-11-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
INBX / Inhibrx Biosciences, Inc.
SKIN / The Beauty Health Company Call
STAA / STAAR Surgical Company
ETNB / 89bio, Inc.
LYRA / Lyra Therapeutics, Inc.
CSTL / Castle Biosciences, Inc.
ILMN / Illumina, Inc.
CCXI / ChemoCentryx Inc
AMLX / Amylyx Pharmaceuticals, Inc.
INSP / Inspire Medical Systems, Inc.
XLO / Xilio Therapeutics, Inc.
TMDX / TransMedics Group, Inc.
NVRO / Nevro Corp.
OM / Outset Medical, Inc.
US10806XAB82 / Bridgebio Pharma, Inc.
DALS / DA32 Life Science Tech Acquisition Corp - Class A
INMD / InMode Ltd.
STE / STERIS plc
KZR / Kezar Life Sciences, Inc.
CGEM / Cullinan Therapeutics, Inc.
VTGN / Vistagen Therapeutics, Inc.
OSUR / OraSure Technologies, Inc.
PIRS / Pieris Pharmaceuticals, Inc.
CVS / CVS Health Corporation
HZNP / Horizon Therapeutics Plc
MIRM / Mirum Pharmaceuticals, Inc.
LNTH / Lantheus Holdings, Inc.
APLS / Apellis Pharmaceuticals, Inc.
LLY / Eli Lilly and Company
BIIB / Biogen Inc.
CRSP / CRISPR Therapeutics AG
APEN / Apollo Endosurgery Inc
DICE / DICE Therapeutics Inc
ANGO / AngioDynamics, Inc.
ADVM / Adverum Biotechnologies, Inc.
IOBT / IO Biotech, Inc.
UTHR / United Therapeutics Corporation
VSTM / Verastem, Inc.
KDNY / Chinook Therapeutics Inc
SUPN / Supernus Pharmaceuticals, Inc.
CUTR / Cutera, Inc.
DXCM / DexCom, Inc.
SRDX / Surmodics, Inc.
AXGN / Axogen, Inc.
PEPG / PepGen Inc.
NVCR / NovoCure Limited
NVO / Novo Nordisk A/S - Depositary Receipt (Common Stock)
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
CRL / Charles River Laboratories International, Inc.
EIGR / Eiger BioPharmaceuticals, Inc.
FATE / Fate Therapeutics, Inc.
FGEN / FibroGen, Inc.
ISRG / Intuitive Surgical, Inc.
THTX / Theratechnologies Inc.
VCEL / Vericel Corporation
ANAB / AnaptysBio, Inc.
ENOV / Enovis Corporation
KRYS / Krystal Biotech, Inc.
EPIX / ESSA Pharma Inc.
IMGO / Imago BioSciences Inc
INCY / Incyte Corporation
IOVA / Iovance Biotherapeutics, Inc.
PLRX / Pliant Therapeutics, Inc.
NVST / Envista Holdings Corporation
TNDM / Tandem Diabetes Care, Inc.
ISEE / IVERIC bio Inc
SKIN / The Beauty Health Company
NARI / Inari Medical, Inc.
EOLS / Evolus, Inc.
CVRX / CVRx, Inc.
NRIX / Nurix Therapeutics, Inc.
ENTA / Enanta Pharmaceuticals, Inc.
EXAS / Exact Sciences Corporation
IRMD / IRADIMED CORPORATION
HUM / Humana Inc.
KROS / Keros Therapeutics, Inc.
ESTA / Establishment Labs Holdings Inc.
ORGO / Organogenesis Holdings Inc.
NPCE / NeuroPace, Inc.
VRDN / Viridian Therapeutics, Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
PEN / Penumbra, Inc.
RCKT / Rocket Pharmaceuticals, Inc.
ACLX / Arcellx, Inc.
CELC / Celcuity Inc.
PCVX / Vaxcyte, Inc.
XENE / Xenon Pharmaceuticals Inc.
YMAB / Y-mAbs Therapeutics, Inc.
IMUX / Immunic, Inc.
NTRA / Natera, Inc.
CCCC / C4 Therapeutics, Inc.
BCAB / BioAtla, Inc.
EDAP / EDAP TMS S.A. - Depositary Receipt (Common Stock)